Vor Biopharma (VOR)
(Delayed Data from NSDQ)
$2.11 USD
+0.01 (0.48%)
Updated Aug 4, 2025 03:59 PM ET
After-Market: $2.09 -0.02 (-0.95%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth C Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
VOR 2.11 +0.01(0.48%)
Will VOR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VOR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VOR
Vor Bio Stock Skyrockets 250% in the Past Week: Here's Why
Vor Biopharma Inc. (VOR)'s Technical Outlook is Bright After Key Golden Cross
VOR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for VOR
Vor Bio (VOR) Appoints Dallan Murray as Chief Commercial Officer
Vor Bio Appoints Seasoned Biotech Executive Dallan Murray as Chief Commercial Officer | VOR ...
Vor Bio appoints Murray as Chief Commercial Officer
Vor Bio (VOR) Strengthens Board with New Appointments | VOR Stock News
Vor Bio Appoints Biotech Industry Leaders Alexander (Bo) Cumbo and Michel Detheux, Ph.D. ...